Medroxyprogesterone Acetate for Refractory Emesis in Cisplatin-Treated Patients

Akito Hata; Nobuyuki Katakami; Shiro Fujita; Aya Horai; Kento Takatori; Takayuki Ose; Naoto Kitajima

doi:10.1089/jpm.2011.0527

Medroxyprogesterone Acetate for Refractory Emesis in Cisplatin-Treated Patients

Journal of Palliative Medicine ◽

10.1089/jpm.2011.0527 ◽

2012 ◽

Vol 15 (10) ◽

pp. 1158-1160 ◽

Cited By ~ 1

Author(s):

Akito Hata ◽

Nobuyuki Katakami ◽

Shiro Fujita ◽

Aya Horai ◽

Kento Takatori ◽

...

Keyword(s):

Medroxyprogesterone Acetate ◽

Refractory Emesis

Download Full-text

Author response for "Bone Mineral Density in Antiretroviral Therapy‐Naïve HIV‐1‐Infected Young Adults using Depot Medroxyprogesterone Acetate or Non‐Hormonal Contraceptives in Uganda"

10.1002/jbm4.10446/v2/response1 ◽

2020 ◽

Author(s):

Flavia Kiweewa Matovu ◽

Martin Nabwana ◽

Noah Kiwanuka ◽

Delia Scholes ◽

Esther Isingel ◽

...

Keyword(s):

Bone Mineral Density ◽

Young Adults ◽

Bone Mineral ◽

Medroxyprogesterone Acetate ◽

Author Response ◽

Mineral Density ◽

Depot Medroxyprogesterone Acetate ◽

Hiv 1

Download Full-text

Depot Medroxyprogesterone Acetate in Teens: A Risk for Bone Health?

PEDIATRICS ◽

10.1542/peds.106.5.1137 ◽

2000 ◽

Vol 106 (5) ◽

pp. 1137-1138 ◽

Cited By ~ 6

Author(s):

Laura K. Bachrach ◽

Tim Cundy ◽

Susan M. Ott

Keyword(s):

Medroxyprogesterone Acetate ◽

Bone Health ◽

Depot Medroxyprogesterone Acetate

Download Full-text

Partial Adrenal Suppression with Prolonged Use of Depo-Provera

Journal of Clinical and Health Sciences ◽

10.24191/jchs.v4i1.7284 ◽

2019 ◽

Vol 4 (1) ◽

pp. 64

Author(s):

Nur Aisyah Zainordin ◽

Fatimah Zaherah Mohamed Shah ◽

Rohana Abdul Ghani

Keyword(s):

Weight Gain ◽

Medroxyprogesterone Acetate ◽

Side Effect ◽

Case Reports ◽

Adrenal Incidentaloma ◽

Adrenal Suppression ◽

Private Pharmacy ◽

Significant Weight Gain ◽

The Past ◽

Depo Provera

A 49-year old patient presented with symptoms of adrenal suppression following an attempt to withdraw Depo-Provera or Depot Medroxyprogesterone Acetate (DMPA) injection. She had been receiving DMPA injections for the past 16 years for contraception. She was initially prescribed DMPA by her gynaecologist but later on began obtaining the medication directly from a private pharmacy without prior consultation from her gynaecologist. Clinically, she had been experiencing significant weight gain and appeared cushingoid. Blood investigations confirmed partial adrenal suppression with presence of an adrenal incidentaloma. This case reports a known side effect of DMPA but occurring at a much lower dose than previously described. It also highlights the need to increase the awareness of the insidious side effect of DMPA and to avoid unsupervised use of the drug.

Download Full-text